Moody National Bank Trust Division acquired a new position in Arxis, Inc. (NASDAQ:ARXS - Free Report) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 22,535 shares of the company's stock, valued at approximately $1,113,000.
Other large investors have also recently added to or reduced their stakes in the company. Squarepoint Ops LLC acquired a new position in shares of Arxis during the second quarter valued at $19,506,000. Alyeska Investment Group L.P. bought a new position in Arxis in the 2nd quarter valued at about $13,842,000. State Street Corp acquired a new position in Arxis during the 2nd quarter valued at about $9,948,000. BlueCrest Capital Management Ltd acquired a new position in Arxis during the 2nd quarter valued at about $7,389,000. Finally, Grandeur Peak Global Advisors LLC bought a new stake in shares of Arxis during the 2nd quarter worth about $2,740,000.
Arxis Stock Performance
NASDAQ ARXS opened at $49.49 on Wednesday. Arxis, Inc. has a 1 year low of $33.15 and a 1 year high of $61.50. The firm has a fifty day moving average of $52.81. The company has a market capitalization of $20.66 billion and a PE ratio of 618.62. The company has a debt-to-equity ratio of 0.38, a current ratio of 5.21 and a quick ratio of 3.79.
Arxis (NASDAQ:ARXS - Get Free Report) last announced its earnings results on Wednesday, July 29th. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.35. The company had revenue of $500.73 million for the quarter. The company's revenue for the quarter was up 25.0% compared to the same quarter last year. On average, research analysts forecast that Arxis, Inc. will post 0.57 earnings per share for the current year.
Wall Street Analysts Forecast Growth
ARXS has been the topic of a number of research analyst reports. Wells Fargo & Company raised their price objective on shares of Arxis from $52.00 to $63.00 and gave the company an "overweight" rating in a research note on Tuesday, August 4th. Morgan Stanley reaffirmed an "overweight" rating and set a $62.00 price target on shares of Arxis in a research note on Monday, August 3rd. Jefferies Financial Group reiterated a "buy" rating and set a $60.00 price target on shares of Arxis in a research report on Sunday, August 2nd. Weiss Ratings assumed coverage on Arxis in a research note on Monday, August 3rd. They issued a "sell (d+)" rating on the stock. Finally, Citigroup upped their price objective on Arxis from $61.00 to $67.00 and gave the company a "buy" rating in a report on Thursday, August 13th. Eleven research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $54.64.
Get Our Latest Stock Report on ARXS
Arxis Profile
(
Free Report)
We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers' most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.
Featured Stories
Want to see what other hedge funds are holding ARXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Arxis, Inc. (NASDAQ:ARXS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arxis wasn't on the list.
While Arxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.